Objectives-The purpose of this study was to compare transvaginal 4-dimensional hysterosalpingo-contrast sonography with laparoscopic chromopertubation and evaluate the former's clinical value in assessing fallopian tubal patency and peritubal adhesion.
I
t is estimated that 30% to 35% of infertility is caused by tubal factors. [1] [2] [3] Thus, the evaluation of tubal patency is a very important part of an infertility examination. In recent years, transvaginal hysterosalpingo-contrast sonography was introduced to assess tubal patency. This method involves injecting a contrast medium through a catheter into the uterine cavity and observing the course of the fallopian tubes, supplemented by contrast medium diffusion in the pelvis to judge tubal patency. It is a simple, cost-effective, and quick procedure. 4 Moreover, it causes neither postsurgical scars nor radiation exposure. Compared with hysterosalpingography, it has been found that women better tolerate hysterosalpingo-contrast sonography, as the pain disappears very rapidly in most cases. [5] [6] [7] The reduced pain profile, when properly explained by physicians and in combination with analgesics and counseling to reduce anxiety, can enhance pain tolerance and makes the entire procedure more conducive to diagnosis.
As contrast media have developed, contrastenhanced sonographic methods have continued to evolve. Originally, hysterosalpingo-contrast sonography used a negative contrast agent: typically air, a hydrogen peroxide solution, or a saline solution. 8, 9 However, aircontrast sonography has the potential risk of an air embolism and the disadvantage of using a negative contrast agent is that the signal may be obfuscated by intestinal gas and cannot provide information on the morphologic characteristics of the tubes. Modern hysterosalpingo-contrast sonography uses a positive contrast agent: microbubbles. 10, 11 With the positive contrast agent, interference from intestinal gas is avoided. As the imaging technique developed, so too did the mode itself, eventually progressing from a 2-dimensional (2D)-only mode to a 3-dimensional (3D) mode. 8, 12 Three-dimensional hysterosalpingo-contrast sonography reduces the dependence on an experienced sonographer that hampered 2D hysterosalpingo-contrast sonography. However, 3D imaging could not be captured in real time, and radiologists were forced to form diagnoses from still images rather than continuous videos. Thus, it was difficult to obtain a satisfying image of the entire fallopian tube. Real-time 3D sonography, often referred to as 4-dimensional (4D) sonography, has overcome the shortcoming of discontinuous 3D imaging and obtains more information. Currently, it is widely applied to fetal imaging. Reports on the combination of contrastenhanced and 4D sonography to assess fallopian tubal patency and peritubal adhesion are rare; thus, we tried to explore that combination in this study. We compared transvaginal 4D hysterosalpingo-contrast sonography with laparoscopic chromopertubation and evaluated its clinical value.
Materials and Methods

Design
This work was a case-control study. The results of 4D hysterosalpingo-contrast sonography were compared with laparoscopic chromopertubation regarding tubal patency and peritubal adhesion.
Patients
This study was conducted in a university hospital between July 2011 and September 2015. Fifty-six patients visiting infertility clinics were included in the study and underwent surgery by their own choice in 1 month. In total, 112 fallopian tubes were assessed. Twenty-five were primarily infertile, and the rest were secondarily infertile. The study was approved by the Ethics Committee of the Third Affiliated Hospital of Southern Medical University, and written patient consent was obtained.
Transvaginal 4D Hysterosalpingo-Contrast Sonography According to a Recent Report 13 
Examination Time
The hysterosalpingo-contrast sonographic procedure was performed on days 3 to 7 after the last menstrual period to avoid retrograde infection through the impaired endometrium or endometriosis. The endometrium continues to grow and the blood vessels in the functional layer of the endometrium dilate 8 days after menstruation, which may easily cause contrast medium intravasation during hysterosalpingo-contrast sonography. The thickened endometrium may result in physiologic stenosis in the interstitial part of the fallopian tube, which causes a false-positive result. Vaginal secretions were tested before hysterosalpingo-contrast sonography to screen for vaginitis.
Equipment and Settings
The equipment included a Voluson E8 Expert ultrasound system (GE Healthcare, Zipf, Austria) and an RIC5-9-D volume transducer (5-9 MHz). Equipment settings for contrast-enhanced 2D sonography were as follows: mechanical index, 0.14, adjusted according to the power output; mode, coded pulse inversion or colorcoded imaging, or both simultaneously; angle, 1798; and sensitivity/pulse repetition interval, 1.5. Equipment settings for contrast-enhanced 3D sonography were as follows: volume box angle, 1798; volume angle, 1208; quality, and mid 1. Equipment settings for contrastenhanced 4D sonography were as follows: volume box angle, 1798; volume angle, 1208; quality, low; direction, up/down; render mode, gradient light; and threshold low, less than 20, adjusted according to the image.
Preliminary Assessment by Transvaginal 2D and 3D Sonography All patients were initially examined by transvaginal 2D sonography to evaluate the uterus and ovaries. The next step was using transvaginal 3D sonography to further identify any abnormalities of the endometrium and uterine cavity.
Preparation for 4D Hysterosalpingo-Contrast Sonography With SonoVue A sterile speculum was inserted into the vagina. The cervix was visualized and disinfected. A 12F Foley catheter (Zhanjiang Star Enterprise Co, Ltd, Guangdong, China) was inserted into the uterine cavity, and the balloon of the catheter was inflated with sterile saline to secure the catheter inside the uterine cavity. Then the speculum was removed, and the balloon placed in the lower uterine cavity was confirmed by sonography.
A 5-mL dose of a spasmolytic was injected into the uterine cavity to anesthetize the uterus. During this procedure, a preliminary assessment of the uterine cavity pressure was made, observing the flow of the spasmolytic and getting a first impression of tubal patency.
Then the transvaginal volume transducer was positioned to visualize a transverse section of the uterus, and a transvaginal 3D prescan was performed. This process aided in identification of the initial plane for 4D hysterosalpingo-contrast sonography. Since the fimbrial tube usually lies on the ipsilateral ovary, the position of the transducer was adjusted to make sure that the bilateral cornua of the uterus and bilateral ovaries were both visible. Generally, the image quality was set to low; the scan angle was enlarged to 1208; and the transducer position was adjusted until it was possible to scan bilateral uterine cornua and ovaries to save time. If the bilateral ovaries were separated too much to be included in a single interest area, the tubes were scanned separately to ensure that the entirety of both fallopian tubes could be imaged. Once the proper plane was found, the transducer was kept stably in place until the entire fallopian tube was visualized.
The contrast agent was prepared by adding 5 mL of 0.9% a sterile saline solution to 59 mg of the sulfur hexafluoride microbubble contrast agent SonoVue (Bracco SpA, Milan, Italy) in a freeze-dried powder. Then 2 mL of the SonoVue solution was diluted into a 20-mL suspension with 0.9% sterile saline solution. A low mechanical index was used while imaging the SonoVue suspension to maximize the microbubble lifetime under sonography.
Four-Dimensional Hysterosalpingo-Contrast Sonography With SonoVue After identification of the proper imaging volume, the 4D hysterosalpingo-contrast sonographic mode was enabled, and the region of interest was maximized. Then SonoVue was injected into the uterus, and the images were saved as 4D cine clips.
Transvaginal 4D Hysterosalpingo-Contrast Sonographic Indices
The types of tubal patency on 4D hysterosalpingocontrast sonography were as follows: patent-the contrast medium flowed fluidly through the tube, filled the uterine cavity and flowed to the uterine horn, through the fallopian tube, finally spraying at the fimbrial end of the tube; and blockage-the contrast medium stopped flowing before filling the entire passage of the fallopian tube or the spraying from the fimbrial end of the tube.
The periovarian diffusion was classified to 4 ranks: rank i-ringlike periovarian diffusion (contrast agent encircling more than two-thirds of the rim of the ovary); rank ii-half ringlike periovarian diffusion (contrast agent encircling two-thirds to half of the rim of the ovary); rank iii-less than half ring-like periovarian diffusion (contrast agent encircling less than half of the rim of the ovary); and rank iv-no periovarian diffusion.
The spray at the fimbrial end of the fallopian tube was classified into 3 grades: grade 0-there was spray at the fimbrial end of the fallopian tube; (2) grade 1-there was spill at the fimbrial end of the fallopian tube, but the spray was not obvious; and grade 2-there was no spill at the fimbrial end of the fallopian tube.
Laparoscopic Chromopertubation Equipment and Settings
The equipment included a television laparoscopic system (Olympus Optical Co, Ltd, Tokyo, Japan), which was composed of an optical system, an inflation system, a suction system, an electrosurgical instrument system, rotatory cutting equipment, and dedicated laparoscopic chromopertubation instruments.
Procedure
Ten to 20 mL of dye was injected into the uterine cavity to judge the patency of the fallopian tubes and the location of any blockages. Tubal patency was assessed via laparoscopic chromopertubation, and fallopian tubes were classified under 2 conditions, patent and blocked. Criteria for classifications were as follows: patent-when injecting dye, the dye spilled out of the fimbrial end of the fallopian tube; and Blocked-No spill from the fimbrial end of the fallopian tube occurred even after pressure was applied to the injection. Peritubal adhesion was assessed by visual observation of whether there was adhesion around the fallopian tube.
Comparisons of 4D Hysterosalpingo-Contrast Sonographic and Laparoscopic Chromopertubation Findings
Because fallopian tubal patency and peritubal adhesion are both related to the normal function of the fallopian tube in receiving the egg, we studied the value of 4D hysterosalpingo-contrast sonography in assessing both of these elements. Fallopian tubal patency was directly compared between 4D hysterosalpingo-contrast sonography and laparoscopic chromopertubation. Since peritubal adhesion may negatively affect the spray at the fimbrial end and periovarian diffusion, peritubal adhesion on chromopertubation was compared with spray and periovarian diffusion on hysterosalpingo-contrast sonography. Periovarian diffusion on hysterosalpingo-contrast sonography was compared between patent and blocked fallopian tubes, as confirmed by chromopertubation.
Statistical Analyses
All statistical analyses were performed with SPSS version 13.0 software for windows (IBM Corporation, Armonk, NY). Data were expressed as means 6 standard deviations or percentages. The Kruskal-Wallis test was adopted for multiple-group comparisons of categorical data; the Mann-Whitney U test was adopted for 2-group comparisons of categorical data; and the v2 test was adopted for a constituent ratio for 2-group comparisons or population rate for multiple-group comparisons. The correlation of the data was analyzed by Spearman rank correlation. P < .05 was considered significant. Table 1 ). Population characteristics are shown in Table 1 .
Results
Comparison of Fallopian
Taking laparoscopic chromopertubation as the reference standard, the sensitivity, specify, positive predictive value, negative predictive value, and Youden index of 4D hysterosalpingo-contrast sonography for diagnosing blocked fallopian tubes were 88.4%, 85.2%, 90.5%, 82.1%, and 0.74, respectively (Table 2 and Figure 1 ). Nine tubes were misdiagnosed as blocked, 4 of which were diagnosed as having proximal tubal blockage, in which the entire passage of the fallopian tube was not enhanced. The remaining 5 tubes did show some enhancement; however, spray was not visible from the fimbria. Of these, 4 did not develop well in the ampullar region, and 1 enlarged in that region. Eight were misdiagnosed as patent, 4 of which were shown by chromopertubation to be blocked at the proximal end and 4 blocked at the distal end.
Four-dimensional hysterosalpingo-contrast sonography identified 20 fallopian tubes with proximal Data are presented as mean 6 SD and number (percent).
He et al-Assessment Methods for Fallopian Tubal Patency and Peritubal Adhesion Figure 1 . Comparison of transvaginal 4D hysterosalpingo-contrast sonography and laparoscopic chromopertubation for assessing tubal patency. A1, The contrast agent filled the uterine cavity, flowed to the uterine horn, through the fallopian tube, and finally sprayed at the fimbral end of the tube.The passage of the tube was soft and tended naturally downward. A2, Dye liquid flowed out of the left tube, proving the tube patent on chromopertubation, which was in agreement with hysterosalpingo-contrast sonography. B1, Only the interstitial portion of the right fallopian tube filled with contrast, and the rest did not enhance on hysterosalpingo-contrast sonography. B2, The isthmic portion of the right fallopian tube (arrows) was slender and did not enlarge even after injection of dye liquid. C1, The entire passage of the left fallopian tube enhanced, and the interstitial, isthmic, and proximal ampullar portions of the fallopian tube filled well, yet the diameter of the distal ampullar portion of the fallopian tube was enlarged, and there was no contrast spill at the fimbrial end on hysterosalpingo-contrast sonography. C2, Hydrosalpinx occurred in the left fallopian tube, which was without opening at the fimbrial end, and there was no dye spilling out of the fallopian tube after injection. obstructions. However, only 11 proved consistent with surgery; therefore, the accuracy was 55.0% (Table 3) . Thirty-two fallopian tubes showed distal obstructions on hysterosalpingo-contrast sonography. Twenty-five proved consistent with surgery; therefore, the accuracy was 78.1% (Table 3) .
Comparison of Spray at the Fimbrial End Between the No-Peritubal Adhesion and Peritubal Adhesion Groups
Seventy percent (32 of 46) of fallopian tubes graded 0 by hysterosalpingo-contrast sonography were confirmed as having no peritubal adhesion on chromopertubation. Forty-four percent (8 of 18) of tubes graded 1 showed peritubal adhesion on chromopertubation, but 56% (10 of 18) showed no evidence of adhesion. Seventy-five percent (36 of 48) of tubes graded 2 were confirmed to have peritubal adhesion (Table 4 ). The spray score at the fimbrial end in the no-peritubal adhesion group was significantly lower than that in the peritubal adhesion group (P < .001; average rank: no peritubal adhesion, 43.9; peritubal adhesion, 68.3).
Comparison of Periovarian Diffusion Between the No-Peritubal Adhesion and Peritubal Adhesion Groups
The periovarian diffusion score in the no-peritubal adhesion group was significantly lower than that in the peritubal adhesion group (P < .001; average rank: no peritubal adhesion, 42.2; peritubal adhesion, 69.8; Z 5 25.060; Table 4 ).
Comparison of Periovarian Diffusion Between the Patent-Tube and Blocked Groups Confirmed by Laparoscopic Chromopertubation
The periovarian diffusion score in the patent group was significantly lower than that in the blocked group (P < .001; average rank: patent, 40.7; blocked, 75.4; Z 5 26.350; Table 4 ).
Discussion
Assessment of fallopian tubal patency is an important part of a routine infertility examination, as tubal obstruction is estimated to play a role in 30% to 35% of infertile couples. [1] [2] [3] In the past, there were 3 diagnostic techniques widely used in the clinic, including hydrotubation, hysterosalpingography, and laparoscopic chromopertubation. However, as it is a subjective method with low accuracy, hydrotubation has fallen into disuse 2  8  6  1  8  2  5  3  2  9  3  1  3 5  Periovarian diffusion  i  40  4  11  10  ii  3  0  1  5  iii  3  1  1  6  Iv  1  2  1  23 He et al-Assessment Methods for Fallopian Tubal Patency and Peritubal Adhesion as a diagnostic method. Although hysterosalpingography is still widely used, not all patients are willing to undergo the procedure, as x-ray irradiation and ionizing radiation do carry some risks. Additionally, it provides no information on the ovaries, uterus, and pelvic disease. Today, laparoscopic chromopertubation is the reference standard for assessing tubal disease. [14] [15] [16] However, it requires general anesthesia and a hospital stay, as well as carrying a risk of intestinal perforation and internal bleeding. Therefore, a simple, minimally invasive technique is still an unmet need in the area of reproductive medicine. Transvaginal 4D hysterosalpingo-contrast sonography is a simple, cost-effective, and short procedure, can be provided in an outpatient setting, and is associated with minimal patient discomfort and a low risk of infection. This procedure is noninvasive and rather easy to perform in almost any medical setting because it does not require sedation or anesthesia, nor does it have any adverse effects or severe related complications. 17 Figure 2. Change in fallopian tube spasm development during 2 rounds of transvaginal 4D hysterosalpingo-contrast sonography. A1, After the first injection of SonoVue, the left cornua uteri was distended, and the fallopian tube did not enhance on hysterosalpingo-contrast sonography. A2, After the second injection, the contrast agent filled the fallopian tube rapidly, and the whole fallopian tube enhanced. B1, After the first injection, the uterine cavity did not enhance clearly, and the fallopian tube did not enhance. B2, After the second injection, the contrast agent filled the fallopian tube rapidly, and the whole fallopian tube enhanced. C1, After the first injection, the uterine cavity did not enhance clearly, and the fallopian tube did not enhance. C2, After the second injection, the contrast agent filled the fallopian tube rapidly, and the whole fallopian tube enhanced.
It is a useful diagnostic tool for identifying tubal factor infertility.
Our study showed 4D hysterosalpingo-contrast sonography to have sensitivity, specificity, positive predictive, and negative predictive values of 88.4%, 85.2%, 90.5%, and 82.1%, respectively. Saunders et al 4 reported agreement rates of 78.1% to 90.9% between hysterosalpingo-contrast sonography and laparoscopic chromopertubation. These values are comparable to hysterosalpingography, which showed sensitivity, specificity, positive predictive, and negative predictive values for detection of fallopian tube blockage of 71.4% to 88.0%, 79.4% to 87.0%, 47.0% to 71.0%, and 83.1% to 94.0%. Reports on hysterosalpingo-contrast sonographic assessment of peritubal adhesion are rare, but this factor is also very important for identifying the cause of infertility in the clinic.
False-positive findings of proximal obstruction may relate to the fallopian tubal anatomic features. The muscular layer of the isthmus of the fallopian tube is quite thick, and the lumen is narrow. Uterine contraction may cause temporary muscle spasms in the tube, which can be misdiagnosed as tubal obstruction (Figure 2 ). Additionally, when the ovary clings to the uterus or is located above the corpus uteri, and the passage of the tube is upward, it can be easily mistaken as proximal tubal obstruction (Figure 3) . Clinically, 80% tubal infertility is caused by middle or distal tubal obstruction. 18 Our study found that 4D hysterosalpingo-contrast sonography and laparoscopic chromopertubation agrees on diagnoses of distal tubal obstruction more often than they did on diagnoses of proximal tubal obstruction. This finding is consistent with a previous study showing that if the obstruction occurs in the middle or distal part of the fallopian tube, an underlying pathologic condition is always present.
2 Therefore, it is necessary to identify as falsepositive findings those resulting from a tubal spasm when diagnosing proximal tubal obstruction. Although uterine distention during contrast agent injection leads to a tubal spasm and pressure increase at the intramural part of the oviduct, that pressure elevation is short lived, lasting 4 to 6 seconds, after which the pressure returns to the predistension value, even if the uterus remains distended. 19 Hence, if a tubal spasm is suspected, clinicians can repeat 4D hysterosalpingo-contrast sonography or increase the contrast medium injection time and dosage. Since the fimbrial end of the fallopian tube extends over the ovary, we can find the location of the ovary to help Figure 3 . Relationship between ovary location and fallopian tube development. A1, The right ovary was close to the uterus. A2, The left ovary was far from the uterus. A3, The passage of the left fallopian tube was naturally downward, and the right one was upward. B1, The right ovary was above the corpus uteri. B2, The left ovary was far from the uterus. B3, The passage of the left fallopian tube was naturally downward, and the right one was upward.
He et al-Assessment Methods for Fallopian Tubal Patency and Peritubal Adhesion us to recognize the distal fallopian tubes. If the ovary is far from the uterus, the fallopian tube develops naturally downward. However, if the ovary is close to the uterus or above the corpus uteri, the fallopian tube may develop upward from the cornua uteri. Therefore, when the ovary clings to the uterus or resides above the corpus uteri, it is very important for us to identify the real tube passage from the cornua uteri. Furthermore, inadequate wedging of the cervical cannula allows leakage of contrast medium into the vagina, thus interfering with the generation of sufficient intracavitary pressure and often leading to misdiagnosis of tubal occlusion. Thus, before 4D hysterosalpingo-contrast sonography, it is best to inject normal saline to preliminarily evaluate tubal patency and ensure that the balloon fully blocks the cervix.
There were 8 fallopian tubes with false-negative findings: 4 with actual proximal obstruction and 4 with distal obstruction. These results indicate that the contrast medium and contrast-enhanced sonographic technique may be relevant to diagnosis. The diameter of the SonoVue microbubble is smaller than that of a red blood cell. Even if the tubal lumen is narrow, the microbubbles can still flow through it smoothly. Moreover, contrastenhanced sonography can greatly improve the signal-tonoise ratio of the fallopian tube compared with the adjacent tissue texture and display the contrast medium filling the fallopian tube with high sensitivity. In contrast, a temporary tubal spasm or poor operator technique may result in a false-positive result even on laparoscopic chromopertubation. It was reported that women did conceive after laparoscopy had shown bilateral tubal occlusion, which might result from a temporary tubal spasm or poor operator technique. 20 The different methods of interrogating fallopian tubal patency all differ in how effectively they show different defects. There is evidence that the accuracy of selective salpingography is better than that of the laparoscopy and dye test in predicting proximal tubal occlusion, but both tests are equivalent in predicting distal tubal occlusion, and the laparoscopy and dye test is better than selective salpingography in predicting peritubal disease. 21 In addition, venous or lymphatic intravasation of the contrast agent can be mistaken as a fallopian tube. With regard to the false-negative case of a distal obstruction, the enlarged fallopian tube may have been mistaken as the fimbrial end on hysterosalpingo-contrast sonography. This possibility provides the basis for a future study: namely, distinguishing an enlarged fallopian tube and the fimbrial end of the tube by observing imaging features and the spouting velocity of the spray from the fimbria.
Periovarian diffusion and the spray from the fimbria are relevant to peritubal adhesion. By observing spray at the fimbrial end of the fallopian tube and periovarian diffusion, peritubal adhesion can be identified. The more obvious the spray at the fimbrial end of the fallopian tube and the better the periovarian diffusion, the lower the possibility of peritubal adhesion. If the fallopian tube is patent and without peritubal adhesion, the contrast medium diffuses rapidly around the ovary in a ringlike shape. However, if there is tight peritubal adhesion, the fimbrial end of the fallopian tube spills little contrast medium. In addition, the diffusion around the ovary will be uneven because of the adhesion. However, it is important to exclude contrast medium diffusion from the off side when observing periovarian diffusion.
All in all, transvaginal 4D hysterosalpingo-contrast sonography is a method with high sensitivity and specificity for screening fallopian tubal patency and peritubal adhesion, which supplies the clinician with both a useful tool for diagnosis and a reference for therapy.
